Zhang et al. found that continuing metformin use after the diagnosis of cirrhosis improves survival by reducing the risk of HCC and death or liver transplantation, reducing the risk of hepatic encephalopathy possibly by inhibiting glutaminase activity and improving sensitivity to insulin [144]. Here, INS is linked to Cirrhosis.